Choose a language and wait for the translated text.
Biocon chairperson Kiran Mazumdar-Shaw calls for greater use of digital technology to speed up drug development, as industry leaders push for a shift beyond generics
'Indian Pharma's Risk Aversion Holding Back Innovation' | PharmaVoice
